Narrows FY24 revenue view to $1.750B-$1.850B from $1.650B-$1.850B. Consensus is for FY24 EPS $1.42 and for revenue $1.76B. Sees FY24 Adjusted EBITDA $165M-$185M.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASTH:
- Astrana Health price target raised to $60 from $48 at Stifel
- Astrana Health price target raised to $60 from $50 at BTIG
- Astrana Health Announces Major Acquisitions and Earnout Agreement
- Astrana Health to acquire Collaborative Health Systems, no terms disclosed
- Astrana Health and Elation Health partner in infrastructure solution